Recursos de Sanidad, Biomedicina y Salud
 
 

Libros sobre ENFERMEDADES INFECCIOSAS

 

Influenza virology

 
Three times in the last century, influenza viruses have undergone major genetic changes resulting in global pandemics that had devastating effects. The most infamous pandemic was the "Spanish Flu" which affected up to 25% of the world population and is thought to have killed at least 40 million people in 1918-1919. More recently, two other influenza pandemics, the "Asian Flu" in 1957 and the "Hong Kong Flu" in 1968, killed millions of people worldwide. These caused severe disease, not only in the young and the elderly, who are usually very susceptible to influenza, but also among healthy younger persons. In 1997 and 2003 a new influenza A virus of H5N1 subtype emerged in Asia and was transmitted directly from birds to humans with lethal outcomes. Despite monumental efforts to contain them, the H5N1 viruses expanded their territory and caused a major outbreak in wild waterfowl in China in 2005. Indeed, they have even been transmitted to Siberia and Kazakhstan. Despite extensive, coordinated efforts by various agencies and disciplines, both national and international, we are ill-equipped for a new influenza pandemic. In fact it is highly unlikely that adequate supplies of vaccine for the H5N1 viruses will be prepared prior to the occurrence of the next pandemic. Many countries are stockpiling influenza drugs, with the hope that the inevitable emergence of drug-resistant viruses will not nullify those efforts immediately. To combat the outbreaks that will undoubtedly occur in the near future a better understanding of influenza virus itself, the virus-host interaction, and mechanisms of drug resistance is urgently needed. In this timely book world renown scientists (including the 1996 Nobel Prize Winner, Peter Doherty) critically review the most important issues in this rapidly expanding field. Topics covered include analysis of influenza RNP, viral entry and intracellular transport, epidemiology, host range and pathogenicity, antivirals, vaccines, H5 viruses, and much more. Essential reading for all influenza virologists, molecular biologists, public health scientists and research scientists in pharmaceutical companies.
 

100 Questions & Answers about Cervical Cancer

 
Two oncologists and the medical director of a sexual health and survivorship program answer questions women typically have after being diagnosed with preinvasive changes or invasive cervical cancer. Simple language sheds light on risk factors, screening, abnormal pap results, the different types of cervical cancer, treatment of locally advanced disease, sexuality after cervical cancer, and fertility.
 

HIV and Aging

 

More than two decades into the global HIV epidemic, Many HIV positive patients who have access to antiretroviral medications are entering the senior citzen age bracket. A growing number of HIV positive patients will now face a new set of complicated medical problems related to aging. HIV and Aging examines the current effects of HIV and HIV medications on the aging patient relating to immune system, neurologic , cardiovascular, pulmonary, renal gastrointestinal, hormonal, bone, joint, and oncological issues.

 

Infectious Diseases: In Context

 

'Infectious Diseases in Context' is a comprehensive guide to the increasingly important topic of emerging and infectious diseases and covers the history, politics, and ethical debate related to infectious diseases. The set includes articles on how such diseases impact trade and commerce, travel and the future of industrialized and impoverished nations. The new book is cross-curricular in nature and supports curriculums in health, biology, advanced biology, and genetics, as well as history, government, and the social sciences. It brings together original essays written by leading experts in the field, primary source documents, and sidebars on the cultural, economic, and political issues surrounding the topic.

 

Skills-building for Gender Mainstreaming in HIV/Aids: Research and Practice

 
Held in Dakar, Senegal in October 2005, this report contains the presentations delivered at the gender and HIV/AIDS-themed sessions held during the 3rd African Conference of the Social Aspects of HIV/AIDS Research Alliance (SAHARA). It contains an overview of critical gender and HIV/AIDS theory, presentations on how to design gender-sensitive research and how to extract gender-relevant data from existing research data, how to move from research to advocacy to policy, and worksheets that can be used in training others to use a gendered lens.
 

HIV/AIDS: A Very Short Introduction

 

HIV/AIDS is without doubt the worst epidemic to hit humankind since the Black Death. First identified in 1981, by 2004 it was estimated that about 40 million people were living with the disease, and about 20 million had died. Despite rapid scientific advances there is still no cure and the drugs are expensive and often toxic. Because of controversies and taboos surrounding safe drug usage and prostitution, the numbers of people infected continues to rise. However, it is in the developing world and especially parts of Africa that the real catastrophe is unfolding. Life expectancy has plummeted to below thirty-five years, leading to a serious decline in economic growth, a sharp rise in orphaning, and the imminent collapse of health care systems. The good news is, there have been unprecedented breakthroughs in understanding the diseases and developing drugs. Because the disease is so closely linked to sexual activity and drug use, the need to understand and change behavior has caused us to reassess what it means to be human and how we should operate in the globalizing world.In this eye opening and hard hitting book, Alan Whiteside uses his professional and personal experience to provide an in-depth look at HIV/AIDS, examining the social issues surrounding the disease, its fascinating demographics, and devastating consequences. He offers a global perspective, covering developed and developing countries, and discusses what steps can be taken medically, politically, and economically, in the hope that one day this disease will be brought under control.

 

Case Studies in Ethics and HIV Research

 
There has been a consistent interest in ethical issues arising in the context of HIV research. Ongoing international and multi-site studies and the continuing search for an HIV vaccine continue to prompt examination of how this research is conducted, how participants are engaged in the studies, and the obligations of the researchers to individual participants and their communities during the course of and following the conclusion of the research. Each chapter is authored primarily by one of the editors (secondarily by the other) and is accompanied by one to two case studies. Each case study has been authored by an HIV/AIDS researcher with experience in the subject matter of the chapter. The case studies will focus on an actual ethical dilemma encountered by the researcher, with suggestions on how it can be resolved. Each chapter addresses relevant issues and emphasizes particular ethical principles.
 

Virus patógenos

 
Monografía sobre la biología de los virus animales y humanos, elaborada por expertos españoles. Patrocinio de la Fundación BBVA.